You are here

Approved but denied

Right now, thousands of people living with MS who experience muscle spasms are facing an unacceptable postcode lottery.

Sativex, a cannabis-based spray, was approved in England in 2019 to treat moderate to severe spasms when other treatments have not worked. Yet many people with MS are still being denied access. Our research shows Sativex is only funded by 49 out of 106 of England’s local health bodies.

Sativex doesn’t work for everyone, but when it does, it can be life changing. That’s why we need as many of us as possible to call on health services across England to ensure everyone who meets the criteria can access Sativex.

The pandemic has had a huge impact on people living with MS, and many missed out on care and support. As the NHS works hard to build back, people with MS must have access to treatment no matter where they live.

Help us make a difference

If you live in England, please take action now – check if Sativex is available in your area and call for change

What’s happening across the other nations?

You can find out more about Sativex across the other nations in the UK on our website by clicking this link

We know that Sativex isn't suitable for everyone. We'll continue to invest in research until the day everyone has treatments, and we stop MS.